• acknowledge writing thank for spouse and my kiddos for help and support me during my journey
  *abstract
  *General introduction
  All about Ebola virus and using figures for number of outbreaks and number of people who are affected
  ‘’By using review articles’’
  *Hypothesis/ objective
  To assess vaccine design studies and their outcomes on efficiency and effective immune response. Several journal articles were reviewed and the data is completed
  *study
  The articles choose for the study
  take each article in this list and summarize the summary, objective,introduction, methods, results ( chose the most important 3 figures), discussion and conclusion
  .Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.
  Elsherif et al. (2017)

•Prevention of Ebola virus disease through vaccination: where we were in 2018
Levy et al. (2018)

•A recombinant vesicular stomatitis virus Ebola vaccine
Regules et al. (2017)

•Immune responses to novel adenovirus type 26 and modified vaccinia virus Ankara–vectored Ebola vaccines at 1 year
Winslow et al. (2017)

•Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomized trial
Henao-Restrepo et al. (2015)

*Discussion

Using these articles

• immune response
  Current Ebola Virus Vaccine Progress
  Marzi & Mire (2019)

-No report on safety concerns
Chimpanzee adenovirus vector Ebola vaccine
Ledgerwood et al. (2017)

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomized trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomized, double-blind, placebo-controlled trial. The Lancet infectious diseases

Tapia et al. (2016)

*statics
*Conclusion
*Reference
*Table of contact